Fundz

Watching Oxeia Biopharmaceuticals? See every signal: funding, hires, M&A, contracts, sentiment.

Book a demoChoose your plan
New|Fundz now works inside Claude2 min

AI made execution free. Knowing first is the whole game now.

The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Oxeia Biopharmaceuticals is looking to raise $20,000

Sep 21, 2026about 3 hours ago

Target Amount

$20,000

Deadline

Sep 24, 2026

CIK0001610315
File Number008-70060

Issuer ContactFrom SEC filing

Legal nameOxeia Biopharmaceuticals, Inc.
Websitewww.oxeiabiopharma.com
Address361 Newbury Street
Boston, MA, 02115

Issuer Information

Issuer

Oxeia Biopharmaceuticals

Location

361 newbury street

boston, massachusetts, united states

G2 High Performer Badge

⚡ Your AI Catches Every Buying Signal

While you sleep, we analyze 1,000+ companies across all strategic moves.

Set your ICP once, then wake up to:

• Companies that just hired key executives

• Fresh funding rounds AND acquisitions

• Product launches & new partnerships

• Your top matches from ALL momentum signals

2 to 50 AI-scored leads daily, by plan

Trusted by sales, BD, and investment teams at Oracle, HubSpot, and more.

Campaign Status

Filing TypeRegulation CF (C/A)
Target Amount$20,000
Securities TypeOther
StateMA

Ending Soon!

2 days remaining

View SEC Filing

Fundz sees it the moment Oxeia Biopharmaceuticals opens a raise, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Michael
Likely contact at this company
••••••••@••••••••

See Michael's verified email →

This company raised through a public offering. Fundz reads the filing itself, not a press release.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

4 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.